| Identification | Back Directory | [Name]
(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) | [CAS]
101403-24-1 | [Synonyms]
Rotigotine InterMediate
(S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-aMine
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine
(2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine
2-NaphthalenaMine, 1,2,3,4-tetrahydro-5-Methoxy-N-propyl-, (S)-
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine HCl
2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methoxy-N-propyl-, (2S)-
(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine) | [Molecular Formula]
C14H21NO | [MDL Number]
MFCD09955349 | [MOL File]
101403-24-1.mol | [Molecular Weight]
219.32 |
| Chemical Properties | Back Directory | [Boiling point ]
346.1±42.0 °C(Predicted) | [density ]
1.01±0.1 g/cm3(Predicted) | [solubility ]
soluble in Methanol | [pka]
10.26±0.20(Predicted) |
| Hazard Information | Back Directory | [Uses]
(S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine is an intermediate in the production of antipsychotic agents and antiparkinson medications. (S)-1,2,3,4-Tetrahydro-5-methoxy-N-propyl-2-naphthalenamine Di-p-toluoyl-L-tartaric Acid Salt is an impurity in the synthesis of ent-Rotigotine (R700705), which is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson’s disease. |
|
| Company Name: |
T&W GROUP
|
| Tel: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
|